Trending Topic
Cardiovascular disease (CVD) continues to be the primary cause of mortality and morbidity globally with middle-aged women presenting with additional and possibly, overlooked risk factors.1 Despite several awareness programmes, there remain several gaps in the political education and representation needs of this group, which includes those from low socioeconomic status (SES) and culturally diverse backgrounds. These […]
The DORIAN GRAY project, an ambitious new initiative funded by the European Union (EU), aims to identify the connection between cardiovascular disease (CVD) and mild cognitive impairment (MCI) to improve healthy aging and survival.1 Spearheaded by the University of Brescia, ...
At #ACVC2025 in Florence, a study on out-of-hospital cardiac arrest (OHCA) highlighted the importance of early cardiopulmonary resuscitation (CPR). Researchers found that rapid CPR initiation, rather than the type of rescuer, significantly impacts survival outcomes. Delays in return of spontaneous circulation (ROSC) led to higher mortality risks.
Novel oral therapy shows a 3.3% increase in left ventricular ejection fraction, marking a potential breakthrough in treating Duchenne muscular dystrophy cardiomyopathy In a positive development for the Duchenne muscular dystrophy (DMD) community, Cumberland Pharmaceuticals (Nashville, TN, USA) has announced positive ...
Watch a leading expert discuss the need for personalised obesity treatment including current evidence for cardiovascular outcomes.
As 2024 draws to a close, we’re celebrating a wonderful year of content. From insightful expert Q&As and peer-reviewed articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the cardiology community with high-quality, easily accessible content.
In this engaging short animation, learn how cholesterol-lowering MTP inhibitors act to reduce cholesterol in people with homozygous familial hypercholesterolemia, and explore clinical data supporting their long-term hepatic safety.
Visionary Voices: Season 1, Episode 7 Join us in this episode as Trudie Lobban, Founder and Trustee of Arrhythmia Alliance, discusses the remarkable work of Pace4Life. This innovative charity repurposes cardiac electronic devices, delivering critical heart care to communities in low- ...
touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.
A recent study has uncovered a significant association between residential exposure to transportation noise and the risk of developing atrial fibrillation (AF). The study, published in The Lancet Regional Health - Europe reveals that individuals exposed to elevated levels of road traffic noise face a 2% increase in the risk of AF for every 10-decibel rise in noise exposure. Notably, this risk was amplified among women and those with higher body mass indices, underscoring the need for heightened awareness of environmental health risks.
A recent study by Ryan Woltzand colleagues from the Howard Hughes Medical Institute (CA, USA) in PNAS reveals that phosphatidylinositol 4,5-bisphosphate (PIP2) plays a critical role in regulating small-conductance Ca²+-activated K⁺ (SK2) channels by disrupting a key salt bridge that modulates channel activation. This discovery not only enhances our understanding of ion channel dynamics but also holds significant promise for the development of targeted therapies for atrial fibrillation (AF).
We’re looking forward to the Heart Rhythm Congress, which is taking place in Birmingham, UK between 6-8 October 2024. Promising attendees an opportunity to explore the largest heart rhythm conference in the UK. We are excited to provide independent, expert ...
The EuroPCR 2024 meeting, the leading global conference in interventional cardiovascular medicine, was a hub of innovation and cutting-edge research. This year’s event in Paris brought together the world's foremost experts, researchers and clinicians to share the latest advancements and breakthroughs in the field. From novel therapeutic approaches to landmark clinical trials, EuroPCR 2024 provided a comprehensive overview of the current and future landscape of cardiovascular care. We selected our top three trials from this year’s late-breaking sessions:
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.